🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Our new paper is now out in nature. Together with #Ning Zhang lab and #Jiye Zhu lab, we define tumor immune microenvironment subtypes of liver cancer and highlight immunosuppressive functions of tumour-associated neutrophils. nature.com/articles/s4158…

The way we communicate SERIOUS NEWS to patients can impact their quality of life. I recommend reading this fantastic article in Gastroenterology. Thanks for the guidance ! bit.ly/3VkgAex #MedTwitter #livertwitter American Gastroenterological Association (AGA)

Our study entitled «Baseline ALBI score and early variation of serum AFP predicts outcomes in patients with HCC treated by atezolizumab-bevacizumab” was recently published in Liver international. onlinelibrary.wiley.com/doi/abs/10.111… Claudia Campani Liver International Here are the main results:

Italian scientists recruited by top US Universities. One more reason to put the hardest efforts to keep the most promising young scientists in OUR system. nature.com/articles/d4397…

📑Assessing unmet needs in liver disease is important! The NEQ-LD is a novel tool 🔧 to help! 🩻 Diagnosis, prognosis, management plan needs! 🩺Better communication needs! 🔑Unmet needs ⬆️ ⬆️ in cirrhosis #LiverTwitter #OpenAccess journals.lww.com/hepcomm/Fullte…

My long-time colleague and friend Ramon Bataller giving an inspiring state-of-art talk at #EASL2023

Our clinical research group at #EASL2023 #EASLCongress

Awarded best oral presentation 👏👏👏 Claudia Campani

Why fatty liver disease progresses more rapidly in WOMEN after menopause ? This important study in Nature Medicine shows that variations in ESTROGEN receptors play a key role. shorturl.at/jqvZ9 #livertwitter Luca Valenti Elisabetta

Special issue on "The cancer-immunity cycle," a concept first introduced by Mellman & Chen in 2013 that provided a framework to understand anti-cancer immunity | Seven articles discussing progress & advances in the field & highlighting key challenges #cancerimmunitycycle

Scintillating session on factors influencing the development of fibrosis. With Anabel Fdz-⛪️ Maite G Fernandez-Barrena The Manresa lab Fabio Marra & Nadezda Apostolova, + rubén francés & Ana Blas-García as chairs 🔥🔥🔥#fibrosis #livertwitter #gastrogeeks #tweak #fibroblast congreso.adeituv.es/fibrosisvalenc…

With my buddy, Ramon, at the fibrosis symposium in Valencia

Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab–bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study - The Lancet Oncology by ⁦@Caldera60373705⁩ ! thelancet.com/journals/lanon…

Our study recently published in Hepatology was highlighted during the #TLM2023 journals.lww.com/hep/abstract/9…

Presenting data on modulation of monocyte cytokine expression in patients with TIPS at #TLM2023 #dmsc #LiverTwitter

I told a patient with MASLD that he only had F1 liver fibrosis. Then he didn't see the need of any diet or exercise. I told him: "Think that MASLD predisposes you to cardiovascular events". And showed him this paper. shorturl.at/loIKV #livertwitter #MedTwitter

I am truly honoured to have had the opportunity and fortune to share this journey with fabulous colleagues and two more than exceptional mentors Jean-Charles Nault Fabio Marra

Why liver cancer is developed in people with diabetes and steatosis before cirrhosis? The reason involves mechanical forces ! This paradigm-shifting paper in nature reveals a new mechanism: VISCOELASTICITY of the matrix. rdcu.be/dxrR3 #livertwitter #MedX

✌️A nice visit by 🇮🇹 medical student #AnnaCoppini from Università di Firenze Azienda Ospedaliero-Universitaria Careggi 🏥Amsterdam UMC 1800endoscope.com 👏 Fabio Marra 🔗Look forward to host her

Hepatic nodules may sometimes be 'elusive' authors.elsevier.com/a/1jdZ-_O1UU8pZ